United States· US:61589-9705_351255df-296e-9dff-e063-6294a90a2b33
No7 Future Renew Damage Reversal Day Cream Sunscreen Broad Spectrum SPF 25
A medicinal product containing avobenzone; octinoxate; octocrylene; octisalate, registered in United States by BCM Cosmetique SAS.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OCTISALATE
- Manufacturer
- BCM Cosmetique SAS
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1161589970521 TUBE in 1 CARTON (61589-9705-2) / 5 g in 1 TUBE (61589-9705-1)
- ndc1161589-9705-2
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Avobenzone; octinoxate; octocrylene; octisalate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b06f9bd3-5dbe-4983-b4eb-33715d7a5825 GET /v1/drugs/b06f9bd3-5dbe-4983-b4eb-33715d7a5825?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".15; .025; .375; .25",
"substance": "AVOBENZONE; OCTINOXATE; OCTOCRYLENE; OCTISALATE",
"productndc": "61589-9705",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/5g; g/5g; g/5g; g/5g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about avobenzone; octinoxate; octocrylene; octisalate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.